Cargando…
Cost-effectiveness of stimulation of the sphenopalatine ganglion (SPG) for the treatment of chronic cluster headache: a model-based analysis based on the Pathway CH-1 study
BACKGROUND: In the recent Pathway CH-1 study, on-demand stimulation of the sphenopalatine ganglion (SPG) by means of an implantable neurostimulation system was proven to be a safe and effective therapy for the treatment of chronic cluster headache. Our objective was to assess the cost-effectiveness...
Autores principales: | Pietzsch, Jan B., Garner, Abigail, Gaul, Charly, May, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441877/ https://www.ncbi.nlm.nih.gov/pubmed/26002638 http://dx.doi.org/10.1186/s10194-015-0530-8 |
Ejemplares similares
-
Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study
por: Schoenen, Jean, et al.
Publicado: (2013) -
Pathway ch-1 study: sphenopalatine ganglion (spg) stimulation for acute treatment of chronic cluster headache (CCH)
por: Schoenen, J, et al.
Publicado: (2013) -
Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache
por: Jürgens, Tim P, et al.
Publicado: (2016) -
Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 months
por: Barloese, Mads C. J., et al.
Publicado: (2016) -
EHMTI-0227. Therapeutic effectiveness of sphenopalatine ganglion (SPG) stimulation for cluster headache – pathway registry study interim results at 6 months
por: Jürgens, TP, et al.
Publicado: (2014)